These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Serum leptin values in relation to bone density and growth hormone-insulin like growth factors axis in healthy men.
    Author: Papadopoulou F, Krassas GE, Kalothetou C, Koliakos G, Constantinidis TC.
    Journal: Arch Androl; 2004; 50(2):97-103. PubMed ID: 14761840.
    Abstract:
    A novel action of leptin on bone formation has recently been described in animals. However, in humans, studies provide data, that, are less conclusive. So far, few studies investigated the leptin-bone density association in males. Moreover, it has been suggested that GH, IGF-1 and IGFBP-3 may be major players in the hormonal or paracrine pathways that regulate bone cell metabolism. Also, leptin has been shown to modulate the GH/IGF pathway. The aim of this study was to clarify further this issue by investigating (a) the influence of serum levels of leptin, GH, IGF-1 and IGFBP-3 on bone mass in various skeletal sites and, (b), the relationship between leptin and the GH/IGF axis. 363 healthy individuals were investigated. BMD and serum leptin, GH, IGF-1 and IGFBP-3 serum levels were assessed. Our results indicate that 11% of healthy males had bone density with T scores </=2.5 SD. No significant differences were found between men with normal and those with reduced BMD with regards to serum leptin, GH, IGF-1 and IGFBP-3 levels. A positive correlation was found between BMD and leptin levels in FN and T, and a negative one between leptin and IGF-1 levels. Further studies are needed before we reach final conclusions.
    [Abstract] [Full Text] [Related] [New Search]